1.대한간학회 (2013). 비알코올 지방간질환 진료 가이드라인.
2.대한당뇨병학회 (2015). 당뇨병 진료지침.
3.대한뇌졸중학회 (2017). 뇌졸중 진료지침.
4.대한비만학회 (2018). 비만치료지침.
5.대한고혈압학회 (2018). 고혈압 진료지침.
6.대한비만학회 (2019.07.10.). 간헐적 단식 열풍에 대한 대한비만학회의 입장. http://general.kosso.or.kr/html/?pmode=BBBS0001300004&smode=view&seq=1231
7.대한비만학회 (2021). Obesity fact sheet.
8.대한영양사협회 (2022.09.01.). 성인비만관리. https://www.dietitian.or.kr/work/business/kb_c_adult_obesity_food.do
9. 한국지질동맥경화학회 (2022). 이상지질혈증 팩트 시트
1.Dattilo AM, Kris-Etherton P. (1992). Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. The American journal of clinical nutrition. 56(2):320-8.
2.Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, et al. (1995). Weight, weight change, and coronary heart disease in women: risk within the'normal'weight range. Jama. 273(6):461-5.
3.Dhurandhar NV, A. R. (1997). Appetite-suppressant drugs and primary pulmonary hypertension. N Engl J Med.
4.Galanis DJ, Harris T, Sharp DS, Petrovitch H. (1998). Relative weight, weight change, and risk of coronary heart disease in the Honolulu Heart Program. American Journal of Epidemiology. 147(4):379-86.
5.Kastarinen, M. J., Nissinen, A. M., Vartiainen, E. A., Jousilahti, P. J., Korhonen, H. J., Puska, P. M., & Tuomilehto,
6.J. O. (2000). Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. Journal of Hypertension,18(3), 255-262.
7.Kastarinen, M. J., Nissinen, A. M., Vartiainen, E. A., Jousilahti, P. J., Korhonen, H. J., Puska, P. M., & Tuomilehto,
8.J. O. (2000). Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. Journal of Hypertension,18(3), 255-262
9.Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England journal of medicine, 348(17), 1625–1638.
10.Oh SW, Shin SA, Yun YH, Yoo T, Huh BY. (2004). Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res. 12:2031-2040.
11.Lustig RH et al. (2004). Obesity, leptin resistance, and the effects of insulin reduction. Int J Obes Relat Metab Disord, 28(10):1344-8.
12.Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J, et al. (2004). Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review. Obes Rev. 5(1):43-50.
13.Van Gaal LF, Mertens IL, Ballaux D. (2005). What is the relationship between risk factor reduction and degree of weight loss? European Heart Journal Supplements. 7(suppl_L):L21-L6.
14.Jee SH, Pastor-Barriuso R, Appel LJ, Suh I, Miller ER 3rd, Guallar E. (2005). Body mass index and incident ischemic heart disease in South Korean men and women. Am J Epidemiol, 162:42-48.
15.Oh SW, Yoon YS, Shin SA. (2005) Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol, 23:4742-4754.
16.Jee SH, Sull JW, Park J, et al. (2006). Body-mass index and mortality in Korean men and women. N Engl J Med, 355:779-787.
17.Beuther, D. A., & Sutherland, E. R. (2007). Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med, 175(7), 661-666. doi:10.1164/rccm.200611-1717OC
18.Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., ... Hunt, S. C. (2007). Long-Term Mortality after Gastric Bypass Surgery. New England Journal of Medicine,357(8), 753-761.
19.Anandacoomarasamy, A., Caterson, I., Sambrook, P., Fransen, M., & March, L. (2007). The impact of obesity on the musculoskeletal system. International Journal of Obesity,32(2), 211-222.
20.Anandacoomarasamy, A., Caterson, I., Sambrook, P., Fransen, M., & March, L. (2007). The impact of obesity on the musculoskeletal system. International Journal of Obesity,32(2), 211-222.
21.Franko DL et al. (2008). The relationship between meal frequency and body mass index in black and white adolescent girls: more is less. Int J Obes (Lond), 32(1):23-9.
22.Jee, S. H., Yun, J. E., Park, E. J., Cho, E. R., Park, I. S., Sull, J. W., ... Samet, J. M. (2008). Body mass index and cancer risk in Korean men and women. International Journal of Cancer,123(8), 1892-1896. doi:10.1002/ijc.23719
23.Gariepy, G., Nitka, D., & Schmitz, N. (2009). The association between obesity and anxiety disorders in the population: A systematic review and meta-analysis. International Journal of Obesity,34(3), 407-419.
24.Buschemeyer WC 3rd et al. (2010). Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice. Prostate, 70(10):1037-43.
25.Castello L et al. (2010). Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. Free Radic Biol Med, 48(1):47-54.
26.Lu J et al. (2011). Alternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 mice. J Neurochem. 117(1):154-63.
27.Hurren KM, B. H. (2011). Lorcaserin: an investigational serotonin 2C agonist for weight loss. Am J Health Syst Pharm.
28.Fryar CD, Carroll MD, Ogden CL. (2011). Prevalence of overweight, obesity, and extreme obesity among adults: United States, trends 1960-1962 through 2009-2010. the US: National Center for Health Statistics.
29.Jung, H.-K., Hong, S. J., Jo, Y., Jeon, S. W., Cho, Y. K., Lee, K. J., ... Han, S.U. (2012). Updated Guidelines 2012 for Gastroesophageal Reflux Disease. The Korean Journal of Gastroenterology, 60(4). doi:10.4166/kjg.2012.60.4.195
30.Klop, B., Elte, J., & Cabezas, M. (2013). Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients,5(4), 1218-1240.
31.Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, et al. (2013). Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. 310(19):2050-60.
32.Group LAR. (2013). Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New England journal of medicine. 369(2):145-54.
33.Moreno B et al. (2014). Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity. Endocrine. 47(3):793-805.
34.Kushner RF. (2014). Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. 56(4):465-72.
35.Mohanan, S., Tapp, H., Mcwilliams, A., & Dulin, M. (2014). Obesity and asthma: Pathophysiology and implications for diagnosis and management in primary care. Experimental Biology and Medicine,239(11), 1531-1540.
36.Johnston BC et al. (2014). JAMA. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis, 312(9):923-33.
37.Kim MK, Lee WY, Kang JH, et al. (2014). 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul), 29:405–409.
38.Avila, C., Holloway, A. C., Hahn, M. K., Morrison, K. M., Restivo, M., Anglin, R., & Taylor, V. H. (2015). An Overview of Links Between Obesity and Mental Health. Current Obesity Reports,4(3), 303-310.
39.Tinsley GM, La Bounty PM. (2015). Effects of intermittent fasting on body composition and clinical health markers in humans. Nutr Rev, 73(10):661-74.
40.Schoenfeld BJ, Aragon AA, Krieger JW. (2015). Effects of meal frequency on weight loss and body composition: a meta-analysis. Nutr Rev, 73(2):69-82.
41.Johnstone A. (2015). Fasting for weight loss: an effective strategy or latest dieting trend? Int J Obes (Lond), 39(5):727-33
42.Jackson VM et al. (2015). Latest approaches for the treatment of obesity. Expert Opin Drug Discov. 10(8):825-39.
43.Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. (2015). Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). Journal of the American College of Cardiology. 65(20):2159-69.
44.Wolfe BM, Kvach E, Eckel RH. (2016). Treatment of Obesity: Weight Loss and Bariatric Surgery. Circ Res. 118(11):1844-55.
45.Bao P-P, Cai H, Peng P, Gu K, Su Y, Shu X-O, et al. (2016). Body mass index and weight change in relation to triple-negative breast cancer survival. Cancer Causes & Control, 27(2):229-36.
46.Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. (2016). American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocrine Practice. 22(s3):1-203.
47.Group LAR. (2016). Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. The Lancet Diabetes & Endocrinology. 4(11):913-21.
48.Martinez-Huenchullan S et al. (2017). The emerging role of skeletal muscle extracellular matrix remodelling in obesity and exercise. Obes Rev. 18(7):776-790.
49.Nordmann AJ et al. (2016). Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med, 166(3):285-93.
50.Wurtman, J., & Wurtman, R. (2017). The Trajectory from Mood to Obesity. Current Obesity Reports,7(1), 1-5.
51.Noakes TD, Windt J. (2017). Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review. Br J Sports Med, 51(2):133-139.
52.Martinussen C et al. (2017). Emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs. 22(1):87-99.
53.Schauer DP, Feigelson HS, Koebnick C, Caan B, Weinmann S, Leonard AC, et al. (2017). Association between weight loss and the risk of cancer after bariatric surgery. Obesity. 25:S52-S7.
54.Jackson SE, Heinrich M, Beeken RJ, Wardle J. (2017). Weight loss and mortality in overweight and obese cancer survivors: a systematic review. PloS one. 12(1):e0169173.
55.Luo J, Chlebowski RT, Hendryx M, Rohan T, Wactawski-Wende J, Thomson CA, et al. (2017). Intentional Weight Loss and Endometrial Cancer Risk. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 35(11):1189-93.
56.Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, et al. (2018). Cardiovascular safety of lorcaserin in overweight or obese patients. New England Journal of Medicine. 379(12):1107-17.
57.Shin DW, Suh B, Park Y, Lim H, Suh Y-S, Yun JM, et al. (2018). Risk of Coronary Heart Disease and Ischemic Stroke Incidence in Gastric Cancer Survivors: A Nationwide Study in Korea. Annals of surgical oncology. 25(11):3248-56.
58.Pareek M, Schauer PR, Kaplan LM, Leiter LA, Rubino F, Bhatt DL. (2018). Metabolic surgery: weight loss, diabetes, and beyond. Journal of the American College of Cardiology. 71(6):670-87.
59.Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. 391(10120):541-51.
60.Seidelmann SB et al. (2018). Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health, 3(9):e419-e428.
61.Kuk JL, Christensen RA, Wharton S. (2019). Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health. Journal of Obesity.
62.Bittner VA. (2019). The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease..Circulation.
63.American Diabetes Association (2019). 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes care, 42(Suppl 1), S81–S89. https://doi.org/10.2337/dc19-S008
64.Yang, Y. S., Han, B. D., Han, K., Jung, J. H., & Son, J. W. (2022). Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prevalence and Obesity-Related Comorbidity Incidence Stratified by Age from 2009 to 2019. Journal of Obesity & Metabolic Syndrome, 31(2), 169.)